Call for papers: Breast cancer biomarkers in diagnostic and translational pathology – Breast Cancer: Targets and Therapy
Taylor & Francis is pleased to invite you to submit your work to an upcoming Article Collection on “Breast cancer biomarkers in diagnostic and translational pathology” in the journal Breast Cancer: Targets and Therapy.
This Article Collection will focus on investigating immunohistochemical and molecular biomarker testing in breast cancer, with particular emphasis on optimizing reproducibility and standardization in routine practice.
Topics of interest include (but are not limited to):
- Technical and interpretative challenges that pathologists and oncologists must consider, especially in the assessment of low and ultra-low HER2 expression and their implications for targeted therapies.
- Predictive biomarkers in breast cancer immunotherapy, as well as emerging markers that inform treatment selection and response.
- Integration of digital pathology approaches and translational surgical pathology studies.
All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this Collection will not be handling the manuscripts (unless they are an Editorial Board member).
Please review the journal scope and author submission instructions prior to submitting a manuscript.
The deadline for submitting manuscripts is 31st December 2026.
Please contact Rebecca Turner at rebecca.turner@tandf.co.uk with any questions or requests for discount codes relating to this Article Collection.
Please be sure to select the appropriate Article Collection from the drop-down menu in the submission system.
SOURCE: Oncology Central
